PDB26 COMPARATIVE EVALUATION OF THE LONG-TERM COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 AND INSULIN GLARGINE IN A SUB-POPULATION OF POORLY CONTROLLED PATIENTS WITH TYPE-2 DIABETES RECEIVING ORAL ANTIDIABETIC AGENTS
Abstract
Authors
D Cobden L Nicklasson P Raskin A Garber JA Ray W Valentine A Palmer S Roze